Literature DB >> 18440453

Clinical failure after uterine artery embolization: evaluation of patient and MR imaging characteristics.

Sundeep S Toor1, Kongteng T Tan, Martin E Simons, Dheeraj K Rajan, J Robert Beecroft, Eran Hayeems, Kenneth W Sniderman.   

Abstract

PURPOSE: To investigate the patient and magnetic resonance (MR) imaging characteristics associated with clinical failure after uterine artery embolization (UAE).
MATERIALS AND METHODS: Seventy-eight consecutive patients who underwent UAE were examined. Contrast-enhanced MR imaging was performed before and 4 months after the procedure, and clinical follow-up was performed at 15 months. Patients were divided into success and failure groups strictly on the basis of their clinical outcomes. Clinical follow-up included evaluation of fibroid symptoms and the need for further treatment after UAE. Findings at pre- and postprocedural MR imaging were compared, and data collected included changes in uterine and fibroid volumes, fibroid location, and fibroid perfusion.
RESULTS: Fifty-eight patients were placed into the success group and 20 into the failure group. There were no differences between the baseline characteristics of the two groups. The reduction in uterine and dominant fibroid volumes was greater in the success group compared with the failure group; however, the difference was not statistically significant (success group: [295/845] 34.9% vs [80/282.5] 28.3%, respectively, P=.18; failure group: [317/733] 43.2% vs [114/337.6] 33.9%, P=.32). The reduction in total fibroid volume was greater in the success group than the failure group ([189.6/393.5] 48.2% vs [148.7/439.9] 33.8%, respectively; P=.02) despite the fact that the percentage of fibroids completely infarcted was similar between the two groups ([136/172] 79% vs [41/50] 82%, P=.77). Pedunculated subserosal fibroids were more common in the failure group than in the success group (P<.03) and did not reduce in volume as significantly (53.8% vs 14.7%, respectively; P=.02).
CONCLUSIONS: In general, the reduction in total fibroid volume after embolization is smaller in patients with poor clinical improvement. In addition, these patients have a higher number of pedunculated subserosal fibroids, and these fibroids tend to reduce in volume to a lesser extent.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18440453     DOI: 10.1016/j.jvir.2007.12.454

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  10 in total

1.  Uterine Artery Embolization in the Management of Symptomatic Uterine Fibroids: An Overview of Complications and Follow-up.

Authors:  Tami C Carrillo
Journal:  Semin Intervent Radiol       Date:  2008-12       Impact factor: 1.513

2.  Structured vs narrative reporting of pelvic MRI for fibroids: clarity and impact on treatment planning.

Authors:  Andrea Franconeri; Jieming Fang; Benjamin Carney; Almamoon Justaniah; Laura Miller; Hye-Chun Hur; Louise P King; Roa Alammari; Salomao Faintuch; Koenraad J Mortele; Olga R Brook
Journal:  Eur Radiol       Date:  2017-12-15       Impact factor: 5.315

3.  Uterine fibroid embolization efficacy and safety: 15 years experience in an elevated turnout rate center.

Authors:  Carmine Di Stasi; Alessandro Cina; Francesco Rosella; Andrea Paladini; Sonia Amoroso; Daniela Romualdi; Riccardo Manfredi; Cesare Colosimo
Journal:  Radiol Med       Date:  2018-01-22       Impact factor: 3.469

4.  Feasibility study on energy prediction of microwave ablation upon uterine adenomyosis and leiomyomas by MRI.

Authors:  M Xia; Z Jing; H Zhi-Yu; C Jian-Ming; Z Hong-Yu; X Rui-Fang; Y Yu; H Yan-Li; D Bao-Wei
Journal:  Br J Radiol       Date:  2014-06-20       Impact factor: 3.039

5.  Ineffectiveness of magnetic resonance imaging enhancement to predict fibroid volume reduction after uterine artery embolization.

Authors:  Ginny Bao; Lizbeth Hu; Hearns W Charles; Amy R Deipolyi
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-07

6.  Research of dose-effect relationship parameters of percutaneous microwave ablation for uterine leiomyomas--a quantitative study.

Authors:  Ma Xia; Zhang Jing; Han Zhi-yu; Yang Yu; Hao Yan-li; Xu Chang-tao; Xu Rui-fang; Zhang Bing-song; Dong Bao-wei
Journal:  Sci Rep       Date:  2014-09-30       Impact factor: 4.379

7.  Monitoring Leiomyoma Response to Uterine Artery Embolization Using Diffusion and Perfusion Indices from Diffusion-Weighted Imaging.

Authors:  Mengqiu Cao; Lijun Qian; Xuebin Zhang; Xinjun Suo; Qing Lu; Huilin Zhao; Jialin Liu; Jianxun Qu; Yan Zhou; Jianrong Xu; Shiteng Suo
Journal:  Biomed Res Int       Date:  2017-08-27       Impact factor: 3.411

Review 8.  Percutaneous High Frequency Microwave Ablation of Uterine Fibroids: Systematic Review.

Authors:  Anna Maria Ierardi; Valeria Savasi; Salvatore Alessio Angileri; Mario Petrillo; Sara Sbaraini; Antonio Pinto; Francesco Hanozet; Anna Maria Marconi; Gianpaolo Carrafiello
Journal:  Biomed Res Int       Date:  2018-01-08       Impact factor: 3.411

9.  Uterine artery embolization for leioyomas, ultrasonography and angiography aspects.

Authors:  I A Horhoianu; V V Horhoianu; D Joita; M Carstoiu; B Dorobat
Journal:  J Med Life       Date:  2012-12-25

10.  Predicting the results of uterine artery embolization: correlation between initial intramural fibroid volume and percentage volume decrease.

Authors:  Piotr Czuczwar; Sławomir Woźniak; Piotr Szkodziak; Ewa Woźniakowska; Maciej Paszkowski; Wojciech Wrona; Paweł Milart; Tomasz Paszkowski; Michał Popajewski
Journal:  Prz Menopauzalny       Date:  2014-09-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.